Ketoconazole Pill

Phase 1Small molecule

HHospital Universitario Dr. Jose E. Gonzalez

Ketoconazole Pill is one of 15 small molecule programs targeting Sleep Restriction. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Sleep RestrictionActive, not recruiting

Postmenopausal WomenActive, not recruiting

Sleep RestrictionPhase 1

Active, not recruiting

Postmenopausal WomenPhase 1

Active, not recruiting

Competition

Competitive Landscape

17 competitors in Postmenopausal Women

#DrugCompanyPhaseTrials

Afinitor

Novartis

Phase 2

4 2

Depo-Testosterone

AAzurity Pharmaceuticals

Phase 2

1 3

Cortrosyn

Novartis

Phase 1

1 4

Orgalutran

OOrganon and Co

Phase 1

1 5

Decadron

AAspen Global Incorporated

Phase 1

1 6

Cortef

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 1

1 7

Phytoestrogen

CCairo University

Phase 3

1 8

Factrel

Ferring

Phase 1

1 9

AGA2118

AAngitia Biopharmaceuticals

Phase 2

2 10

Recombinant Human Luteinizing Hormone

Merck & Co.

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Postmenopausal Women1 trial

Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women

Active, not recruiting·LLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center·Phase 1·NCT04037605·5 enrolled

Chronic Myelogenous Leukemia1 trial

Cytochrome P450 Inhibition to Decrease Dosage of Dasatinib for Chronic Myelogenous Leukemia

Unknown status·HHospital Universitario Dr. Jose E. Gonzalez·Phase 2·NCT05638763·15 enrolled

Sleep Restriction1 trial

Hormonal Mechanisms of Sleep Restriction - Axis Study

Active, not recruiting·PPeter y. Liu·Phase 1·NCT03142893·80 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Ketoconazole Pill. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ketoconazole Pill compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ketoconazole Pill. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hospital Universitario Dr. Jose E. Gonzalez company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: HHospital Universitario Dr. Jose E. Gonzalez

Ketoconazole Pill

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Postmenopausal Women1 trial

Chronic Myelogenous Leukemia1 trial

Sleep Restriction1 trial

References

Drug Info

Quick Facts

Related News